Three-year outcomes of Supera interwoven nitinol stents versus Eluvia drug-eluting stents in severely calcified femoropopliteal lesions
Journal of Vascular Surgery · 2026
DOI: 10.1016/j.jvs.2026.06.068 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2026. Verfasst von Takashi Yanagiuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan. Electronic address: takashi.yanagiuchi@gmail.com. Hauptthemen laut MEDLINE: Alloys, Popliteal Artery, Drug-Eluting Stents, Femoral Artery. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To compare the 3-year outcomes of Supera interwoven nitinol stents (IWNS) and Eluvia fluoropolymer-based drug-eluting stents (DES) in patients with severely calcified femoropopliteal (FP) lesions. METHODS: This multicenter retrospective study evaluated 3-year outcomes in the same cohort from eight cardiovascular centers in Japan. A total of 257 consecutive patients underwent endovascular therapy using IWNS (n = 123) or DES (n = 134) for FP lesions with severe calcification, defined as Peripheral Arterial Calcium Scoring System grade 3 or 4, between April 2018 and December 2021. Propensity score (PS) matching yielded 69 well-balanced pairs. The primary outcome was 3-year freedom from target lesion revascularization (TLR). Secondary outcomes included primary patency, overall survival, and limb salvage. Interaction analysis was performed to evaluate heterogeneity of treatment effect on TLR risk. RESULTS: The mean follow-up period was 34.3 ± 23.6 months. In the PS-matched cohort, the 3-year freedom from TLR did not differ significantly between the IWNS and DES groups (80.2% vs 78.2%; P = .868). The 3-year primary patency rates were also comparable (69.6% vs 78.8%; P = .558). No significant between-group differences were observed in overall survival (72.8% vs 55.2%; P = .110) or limb salvage (96.0% vs 93.0%; P = .792). Interaction analysis showed significant interactions for age and lesion length, with DES associated with a greater increase in TLR risk in patients aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan. Electronic address: takashi.yanagiuchi@gmail.com.
- Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
- Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
- Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
- Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
- Department of Cardiology, Tenyoukai Central Hospital, Kagoshima, Japan.
Zitieren
APA
Yanagiuchi, T., Tokuda, T., Yoshioka, N., Kojima, S., Tanaka, A., Takei, T., Ogata, K., Yamaguchi, K., Nakama, T., Yokoi, H., & LEADers PAD investigators (2026). Three-year outcomes of Supera interwoven nitinol stents versus Eluvia drug-eluting stents in severely calcified femoropopliteal lesions. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2026.06.068
Vancouver
Yanagiuchi T, Tokuda T, Yoshioka N, Kojima S, Tanaka A, Takei T, et al. Three-year outcomes of Supera interwoven nitinol stents versus Eluvia drug-eluting stents in severely calcified femoropopliteal lesions. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2026.06.068
BibTeX
@article{Yanagiuchi2026,
author = {Yanagiuchi, Takashi and Tokuda, Takahiro and Yoshioka, Naoki and Kojima, Shunsuke and Tanaka, Akiko and Takei, Tatsuro and Ogata, Kenji and Yamaguchi, Kohei and Nakama, Tatsuya and Yokoi, Hirokazu and LEADers PAD investigators, LEADers PAD investigators},
title = {Three-year outcomes of Supera interwoven nitinol stents versus Eluvia drug-eluting stents in severely calcified femoropopliteal lesions},
journal = {Journal of Vascular Surgery},
year = {2026},
doi = {10.1016/j.jvs.2026.06.068}
}
EUVIMED